Granules India Ltd Q1 FY27 Results Analysis: PAT Jumps 60%, EBITDA Margin Expands 256 bps

Granules India Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,476.77 Cr (+22.04% YoY) and PAT growth of +59.77% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue grew 22% YoY, PAT grew 60% YoY, and EBITDA margin expanded 256 bps to 22.95%. Subsidiary operations now drive 60% of PAT, with Senn Chemicals full quarter contributing. Key catalysts include Sodium Oxybate ER FTF and Chantilly VAI clearance, while Gagillapur warning letter remains unresolved.

Key Investment Insights

Key Positives

• Consolidated revenue grew 22.04% YoY to Rs.1,476.77 Cr
• PAT grew 59.77% YoY to Rs.179.96 Cr; normalized PAT up 35.49% YoY
• EBITDA margin expanded 256 bps YoY to 22.95%
• Gross margin at 65.61%, within the top end of management's 64-65% target
• Subsidiary PAT surged 151% YoY to Rs.108.22 Cr, now 60% of consolidated PAT
• No exceptional items in Q1FY27 vs Rs.25.91 Cr charge in Q1FY26
• Finance costs fell 11.17% YoY and 35.38% QoQ, reflecting debt reduction

Risk Factors

• EBITDA margin of 22.95% missed the earlier 24-25% target, though management had stepped back from that guidance
• Gagillapur USFDA warning letter remains unresolved; no update on re-inspection timeline
• Standalone revenue declined 1.03% YoY, indicating reliance on subsidiaries for growth
• Raw material cost escalation remains a risk, though mitigated in Q1
• Effective tax rate rose to 25.14% from 22.06% in Q1FY26, partly due to base effects